"The Future is bright, they just got to sort out the Profit Margins and Operating costs."
Several anecdotes and a number of channel checks by others over the past 6 months were indicating a bit of a land grab for qualified and experienced pathology staff, which were in short-supply.
I suspect this is a primary reason for the sloppy operating margin performance in the half. And the margin impact is twofold: the obvious part, higher costs, but staff shortages results in capacity under-utlilisation and reduced ability to fractionalise fixed costs due to the foregone revenue.
Problem is that companies like SHL are effectively paid by the government for their services on a contracted rate, so when their costs go up, they need to simply cop it in the short-term, before re-contracted pricing terms restore margins.
.
- Forums
- ASX - By Stock
- SHL
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-12
Featured News
Add SHL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$27.99 |
Change
1.790(6.83%) |
Mkt cap ! $13.44B |
Open | High | Low | Value | Volume |
$26.51 | $28.20 | $26.43 | $45.47M | 1.641M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 138 | $27.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.00 | 4545 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 880 | 27.950 |
1 | 5616 | 27.890 |
2 | 4431 | 27.870 |
1 | 1322 | 27.850 |
1 | 773 | 27.840 |
Price($) | Vol. | No. |
---|---|---|
28.000 | 2476 | 2 |
28.050 | 38 | 1 |
28.100 | 7200 | 3 |
28.140 | 825 | 2 |
28.150 | 5772 | 1 |
Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
Featured News
SHL (ASX) Chart |